Description
Hormone therapy can have many benefits for menopausal people. Despite this, prescriptions steeply declined after the Women’s Health Initiative – the largest and longest-running study on women’s health in the U.S. since the early 1990s – found an increased risk of breast cancer among those on menopausal hormone therapy. This created substantial fear around using hormone therapy among providers and patients alike.
However, inconsistencies and biases in the study’s findings have arisen over the years, leading researchers to scrutinize the data more closely. Furthermore, the Food and Drug Administration began removing the black box warnings – which signal serious health risks – on hormone therapy for menopause in November 2025.
Author
Versha Pleasant
Publication Date
July 30, 2026
Publication
The Conversation
Source
Language
English
